Arthritis, Rheumatoid  >>  GSK3117391  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK3117391 / GSK
NCT01934101 / 2013-004342-42: Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers

Terminated
1
64
Europe
CHR-5154, Placebo
GlaxoSmithKline
Arthritis, Rheumatoid
05/14
05/14

Download Options